Published: February 2012
This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.
Millions of Americans have a substance use disorder. Find a treatment facility near you.
Free and confidential support for people in distress, 24/7.
Find treatment facilities confidentially and anonymously, 24/7.
Treatment referral and information, 24/7.
Visit the SAMHSA Facebook page
Visit SAMHSA on Twitter
Visit the SAMHSA YouTube channel
Visit SAMHSA on LinkedIn
To sign up for updates or to access your subscriber preferences, please enter your contact information.
Have a question about government service? Contact USA.gov.